v3.25.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Beginning Balances at Dec. 31, 2023 $ 48,246,027 $ 111,535 $ 49,229,020 $ (1,094,528)
Beginning Balance, shares at Dec. 31, 2023   11,153,513    
Restricted stock grants issued   $ 1,144 (1,144)  
Restricted stock grants issued, Shares   114,378    
Restricted stock grant forfeiture   $ (8) 8  
Restricted stock grant forfeitures, shares   (843)    
Stock-based compensation 71,004   71,004  
Net income 266,150     266,150
Dividends (808,568)     (808,568)
Ending Balance at Mar. 31, 2024 47,774,613 $ 112,671 49,298,888 (1,636,946)
Ending Balance, shares at Mar. 31, 2024   11,267,048    
Beginning Balances at Dec. 31, 2023 48,246,027 $ 111,535 49,229,020 (1,094,528)
Beginning Balance, shares at Dec. 31, 2023   11,153,513    
Net income 857,680      
Ending Balance at Jun. 30, 2024 47,622,227 $ 112,668 49,371,816 (1,862,257)
Ending Balance, shares at Jun. 30, 2024   11,266,761    
Beginning Balances at Mar. 31, 2024 47,774,613 $ 112,671 49,298,888 (1,636,946)
Beginning Balance, shares at Mar. 31, 2024   11,267,048    
Restricted stock grants issued   $ 4 (4)  
Restricted stock grants issued, Shares   400    
Restricted stock grant forfeiture   $ (7) 7  
Restricted stock grant forfeitures, shares   (687)    
Stock-based compensation 72,925   72,925  
Net income 591,530     591,530
Dividends (816,841)     (816,841)
Ending Balance at Jun. 30, 2024 47,622,227 $ 112,668 49,371,816 (1,862,257)
Ending Balance, shares at Jun. 30, 2024   11,266,761    
Beginning Balances at Dec. 31, 2024 $ 47,437,677 $ 112,927 49,559,986 (2,235,236)
Beginning Balance, shares at Dec. 31, 2024 11,292,772 11,292,772    
Restricted stock grants issued   $ 460 (460)  
Restricted stock grants issued, Shares   45,994    
Restricted stock grant forfeiture   $ (3) 3  
Restricted stock grant forfeitures, shares   (375)    
Stock-based compensation $ 100,736   100,736  
Net income 555,152     555,152
Dividends (818,726)     (818,726)
Ending Balance at Mar. 31, 2025 47,274,839 $ 113,384 49,660,265 (2,498,810)
Ending Balance, shares at Mar. 31, 2025   11,338,391    
Beginning Balances at Dec. 31, 2024 $ 47,437,677 $ 112,927 49,559,986 (2,235,236)
Beginning Balance, shares at Dec. 31, 2024 11,292,772 11,292,772    
Net income $ 1,219,368      
Ending Balance at Jun. 30, 2025 $ 47,189,264 $ 113,382 49,732,485 (2,656,603)
Ending Balance, shares at Jun. 30, 2025 11,338,241 11,338,241    
Beginning Balances at Mar. 31, 2025 $ 47,274,839 $ 113,384 49,660,265 (2,498,810)
Beginning Balance, shares at Mar. 31, 2025   11,338,391    
Restricted stock grants issued   $ 3 (3)  
Restricted stock grants issued, Shares   350    
Restricted stock grant forfeiture   $ (5) 5  
Restricted stock grant forfeitures, shares   (500)    
Stock-based compensation 72,218   72,218  
Net income 664,216     664,216
Dividends (822,009)     (822,009)
Ending Balance at Jun. 30, 2025 $ 47,189,264 $ 113,382 $ 49,732,485 $ (2,656,603)
Ending Balance, shares at Jun. 30, 2025 11,338,241 11,338,241